Genome News and Research

RSS
Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

23 Mar 2022
SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

23 Mar 2022
Researchers find two gene variants linked to accelerated aging in childhood cancer survivors

Researchers find two gene variants linked to accelerated aging in childhood cancer survivors

23 Mar 2022
Scientists identify a promising strategy for stopping Ebola virus polymerase

Scientists identify a promising strategy for stopping Ebola virus polymerase

23 Mar 2022
The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

22 Mar 2022
BGI discovery could pave the way for advances in organ regeneration and synthetic biology

BGI discovery could pave the way for advances in organ regeneration and synthetic biology

22 Mar 2022
Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

22 Mar 2022
Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

22 Mar 2022
Study explores minimal classroom transmission of COVID-19 in a large urban university

Study explores minimal classroom transmission of COVID-19 in a large urban university

22 Mar 2022
Using CRISPR/Cas to develop biosafety materials

Using CRISPR/Cas to develop biosafety materials

21 Mar 2022
AI system can help detect the degree and severity of heart transplant rejection

AI system can help detect the degree and severity of heart transplant rejection

21 Mar 2022
Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

21 Mar 2022
Study evaluates colorimetric sensors for SARS-CoV-2 detection using gold nanoparticles

Study evaluates colorimetric sensors for SARS-CoV-2 detection using gold nanoparticles

21 Mar 2022
Clinical severity of SARS-CoV-2-Omicron infection found to be lower than Delta infection

Clinical severity of SARS-CoV-2-Omicron infection found to be lower than Delta infection

21 Mar 2022
Multiple inter-variant recombination events identified in Omicron subvariants

Multiple inter-variant recombination events identified in Omicron subvariants

20 Mar 2022
Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

20 Mar 2022
Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

20 Mar 2022
Hypoxia-inducible factors and SARS-CoV-2 manifestations

Hypoxia-inducible factors and SARS-CoV-2 manifestations

18 Mar 2022
Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

18 Mar 2022
New discovery points to potential drug targets for ASXL1-mutant chronic myelomonocytic leukemia

New discovery points to potential drug targets for ASXL1-mutant chronic myelomonocytic leukemia

18 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback